- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Class A, Class B non notified medical devices must enter licencing regime effective on October 10, 2022
New Delhi: Referring the previous notification No. G.S.R. 102(E) dated 11.02.2020, the Government of India, the Director-General of Health Services, Central Drug Standard Control Organization (CDSCO) has stated that all non-notified medical devices of Class A and Class B categories are scheduled to enter licensing regime with effect from 01.10.2022.
Furthermore through the notice, the Government of India, the Director-General of Health Services, Central Drug Standard Control Organization (CDSCO) has elucidated the manufacturers about the prescribed regulatory pathway for obtaining the licensure for all the non-notified medical devices of Class A and Class B categories.
According to the New Medical Rules,2017 there are four categories for medical devices. Class A, Class B, Class C, and Class D are the various divisions. Medical devices classified as Class A and Class B are regarded as having minimal and moderate risks, respectively. The State Licensing Authority submits an application to produce medical devices that fall under these categories. Devices that pose a High or Very High risk include Class C and Class D devices. The Central Licensing Authority must receive the application for manufacturing them.
A transition period of 30 months had been provided for Class A & Class B medical devices from date of implementation of G.S.R. 102(E) i.e., 01.04.2020 for the transition to licensing regime. During that period the manufacturers were required to register their products on the on the portal (https://cdscomdonline.gov.in/NewMedDev/Homepage) established for the purpose of CDSCO and to affix the registration number on the label of such registered medical devices.
However, as per the recently published notification, the authorities noticed that some other entities are issuing quality certificates to the manufacturers at their level, which had become confusing for manufacturers about the prescribed regulatory pathway for obtaining the licensure for all the medical devices under Medical Device Rules (MDR),2017 by the competent Licensing Authority.
In this regards, the notice stated, "it is hereby clarified that such quality certificates issued by other entities shall not be a replacement of licensure to be granted under MDR, 2017 by the competent Licensing Authority."
"All manufacturers shall have to comply with the licensing requirement and obtain the license aa per MDR, 2017, as the said rules do not recognize any such certificates which are not mentioned in it or part of it.", the notice further added.
In addition to this, advising on the process of obtaining manufacturing license, the Director-General of Health Services, Central Drug Standard Control Organization (CDSCO) clearly stated, "It is again advised that all manufacturers shall apply for obtaining manufacturing license for Class A & Class B medical devices through CDSCO's on-line portal so that the manufacturing license can be granted by respective State Licensing Authorities after review of the applications and audit (as the case may be) as per stipulated time specified in MDR, 2017 in order to avoid further delay."
In this regard this office has proactively taken up the issue vide notice No. 29/Misc/03/2022- DC (94) dated 25.04.2022, requesting all State Licensing Authorities (SLAs) to dispose of the applications received by them as per MDR, 2017 in time to avoid the disruption of the supply of such devices to the paients.
Doctor of Pharmacy
Dr. Divya Colin, a Doctor of Pharmacy Graduate with extensive experience in clinical and hospital settings and confidently equipped with diagnostic and therapeutic skills. She also has spread out exposure to Oncology Departments in Mysore Medical College and Research Institute as Oncology Pharmacist. Currently she is building a career in clinical research and clinical data management. She has been a part of Medical Dialogue since January 2022.